☆ 4.7 Article

Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

JOURNAL OF CLINICAL ONCOLOGY (2013)

Get Full Text
Add to Collection

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 1, Pages 131-161

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2012.47.1938

Keywords

-

Categories

Oncology

Funding

  1. Eli Lilly
  2. Pfizer
  3. Genentech
  4. Merrimack
  5. Medimmune
  6. GlaxoSmithKline
  7. Foundation Medicine
  8. Exelixis
  9. Ambit
  10. Ascenta
  11. Chroma
  12. Genzyme
  13. Millennium Pharmaceuticals
  14. Novartis
  15. sanofi-aventis
  16. Sunesis
  17. Janssen Pharmaceuticals
  18. Merck
  19. UCB Pharma
  20. Bristol-Myers Squibb
  21. Bayer HealthCare Pharmaceuticals
  22. Takeda Pharmaceuticals
  23. Astella Pharma

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.